196 related articles for article (PubMed ID: 32341036)
1. p27 as a Transcriptional Regulator: New Roles in Development and Cancer.
Razavipour SF; Harikumar KB; Slingerland JM
Cancer Res; 2020 Sep; 80(17):3451-3458. PubMed ID: 32341036
[TBL] [Abstract][Full Text] [Related]
2. p27 transcriptionally coregulates cJun to drive programs of tumor progression.
Yoon H; Kim M; Jang K; Shin M; Besser A; Xiao X; Zhao D; Wander SA; Briegel K; Morey L; Minn A; Slingerland JM
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7005-7014. PubMed ID: 30877256
[TBL] [Abstract][Full Text] [Related]
3. Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion.
Podmirseg SR; Jäkel H; Ranches GD; Kullmann MK; Sohm B; Villunger A; Lindner H; Hengst L
Oncogene; 2016 Sep; 35(35):4580-90. PubMed ID: 26829051
[TBL] [Abstract][Full Text] [Related]
4. p27
Bencivenga D; Caldarelli I; Stampone E; Mancini FP; Balestrieri ML; Della Ragione F; Borriello A
Cancer Lett; 2017 Sep; 403():354-365. PubMed ID: 28687353
[TBL] [Abstract][Full Text] [Related]
5. p27 as Jekyll and Hyde: regulation of cell cycle and cell motility.
Larrea MD; Wander SA; Slingerland JM
Cell Cycle; 2009 Nov; 8(21):3455-61. PubMed ID: 19829074
[TBL] [Abstract][Full Text] [Related]
6. p27(Kip1) signaling: Transcriptional and post-translational regulation.
Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
[TBL] [Abstract][Full Text] [Related]
7. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma.
Denicourt C; Saenz CC; Datnow B; Cui XS; Dowdy SF
Cancer Res; 2007 Oct; 67(19):9238-43. PubMed ID: 17909030
[TBL] [Abstract][Full Text] [Related]
8. The non-canonical functions of p27(Kip1) in normal and tumor biology.
Sharma SS; Pledger WJ
Cell Cycle; 2016 May; 15(9):1189-201. PubMed ID: 27082696
[TBL] [Abstract][Full Text] [Related]
9. p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma.
Currier AW; Kolb EA; Gorlick RG; Roth ME; Gopalakrishnan V; Sampson VB
Sci Rep; 2019 Apr; 9(1):6161. PubMed ID: 30992462
[TBL] [Abstract][Full Text] [Related]
10. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.
Chu IM; Hengst L; Slingerland JM
Nat Rev Cancer; 2008 Apr; 8(4):253-67. PubMed ID: 18354415
[TBL] [Abstract][Full Text] [Related]
11. p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.
Pippa R; Espinosa L; Gundem G; García-Escudero R; Dominguez A; Orlando S; Gallastegui E; Saiz C; Besson A; Pujol MJ; López-Bigas N; Paramio JM; Bigas A; Bachs O
Oncogene; 2012 Sep; 31(38):4207-20. PubMed ID: 22179826
[TBL] [Abstract][Full Text] [Related]
12. Interchangeable Roles for E2F Transcriptional Repression by the Retinoblastoma Protein and p27KIP1-Cyclin-Dependent Kinase Regulation in Cell Cycle Control and Tumor Suppression.
Thwaites MJ; Cecchini MJ; Passos DT; Welch I; Dick FA
Mol Cell Biol; 2017 Jan; 37(2):. PubMed ID: 27821477
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
14. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.
Grimmler M; Wang Y; Mund T; Cilensek Z; Keidel EM; Waddell MB; Jäkel H; Kullmann M; Kriwacki RW; Hengst L
Cell; 2007 Jan; 128(2):269-80. PubMed ID: 17254966
[TBL] [Abstract][Full Text] [Related]
15. A cancer-associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss-of-function.
Bencivenga D; Stampone E; Aulitto A; Tramontano A; Barone C; Negri A; Roberti D; Perrotta S; Della Ragione F; Borriello A
Mol Oncol; 2021 Apr; 15(4):915-941. PubMed ID: 33316141
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic p27
Calvayrac O; Nowosad A; Cabantous S; Lin LP; Figarol S; Jeannot P; Serres MP; Callot C; Perchey RT; Creff J; Taranchon-Clermont E; Rouquette I; Favre G; Pradines A; Manenti S; Mazieres J; Lee H; Besson A
J Pathol; 2019 Jan; 247(1):60-71. PubMed ID: 30206932
[TBL] [Abstract][Full Text] [Related]
17. The role of p27(Kip1) phosphorylation at serine 10 in the migration of malignant glioma cells in vitro.
Wang D; He F; Zhang L; Zhang F; Wang Q; Qian X; Pan X; Meng J; Peng C; Shen A; Chen J
Neoplasma; 2011; 58(1):65-73. PubMed ID: 21067268
[TBL] [Abstract][Full Text] [Related]
18. p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes.
Orlando S; Gallastegui E; Besson A; Abril G; Aligué R; Pujol MJ; Bachs O
Nucleic Acids Res; 2015 Aug; 43(14):6860-73. PubMed ID: 26071952
[TBL] [Abstract][Full Text] [Related]
19. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
[TBL] [Abstract][Full Text] [Related]
20. p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.
Wander SA; Zhao D; Slingerland JM
Clin Cancer Res; 2011 Jan; 17(1):12-8. PubMed ID: 20966355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
